![]() |
|
|
Vol. 59, Issue 2, 220-224, February 2001
Institut für Pharmakologie und Toxikologie,
Karl-Franzens-Universität Graz, Graz, Austria (K.S., A.S., B.M.),
and Institut für Pharmakologie und Toxikologie,
Ruhr-Universität Bochum, Bochum, Germany (D.K.)
YC-1 is a direct activator of soluble guanylyl cyclase (sGC) and
sensitizes the enzyme for activation by nitric oxide (NO) and CO.
Because the potentiating effect of YC-1 on NO-induced cGMP formation in
platelets and smooth muscle cells has been shown to be substantially
higher than observed with the purified enzyme, the synergism between
heme ligands and YC-1 is apparently more pronounced in intact cells
than in cell-free systems. Here, we investigated the mechanisms
underlying the synergistic activation of sGC by YC-1 and NO in
endothelial cells. Stimulation of the cells with YC-1 enhanced cGMP
accumulation up to ~100-fold. The maximal effect of YC-1 was more
pronounced than that of the NO donor DEA/NO (~20-fold increase in
cGMP accumulation) and markedly diminished in the presence of
L-NG-nitroarginine, EGTA, or
oxyhemoglobin. Because YC-1 did not activate endothelial NO synthase,
the pronounced effect of YC-1 on cGMP accumulation was apparently
caused by a synergistic activation of sGC by YC-1 and basal NO. The
effect of YC-1 was further enhanced by addition of DEA/NO, resulting in
a ~160-fold stimulation of cGMP accumulation. Thus, YC-1 increased
the NO-induced accumulation of cGMP in intact cells by ~8-fold.
Addition of endothelial cell homogenate increased the stimulatory
effect of YC-1 on NO-activated purified sGC from 1.2- to 3.7-fold. This
effect was not observed with heat-denatured homogenates, suggesting
that a heat-labile factor present in endothelial cells potentiates the
effect of YC-1 on NO-activated sGC.
This article has been cited by other articles:
![]() |
B. Roy, E. J. Halvey, and J. Garthwaite An Enzyme-linked Receptor Mechanism for Nitric Oxide-activated Guanylyl Cyclase J. Biol. Chem., July 4, 2008; 283(27): 18841 - 18851. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Linder, L. P. McCluskey, K. R. Cole III, K. M. Lanning, and R. C. Webb Dynamic Association of Nitric Oxide Downstream Signaling Molecules with Endothelial Caveolin-1 in Rat Aorta J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 9 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Balashova, F.-J. Chang, M. Lamothe, Q. Sun, and A. Beuve Characterization of a Novel Type of Endogenous Activator of Soluble Guanylyl Cyclase J. Biol. Chem., January 21, 2005; 280(3): 2186 - 2196. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Xu, V. Gavrilyuk, H. M. Wolde, V. L. Baughman, and D. A. Pelligrino Regulation of rat pial arteriolar smooth muscle relaxation in vivo through multidrug resistance protein 5-mediated cGMP efflux Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H2020 - H2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Grosser and H. Schroder Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP Pathway Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1345 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Thorsteinsson, R. L. Kerby, H. Youn, M. Conrad, J. Serate, C. R. Staples, and G. P. Roberts Redox-mediated Transcriptional Activation in a CooA Variant J. Biol. Chem., July 13, 2001; 276(29): 26807 - 26813. [Abstract] [Full Text] [PDF] |
||||